Charles Davies

Associate

Biography

Charles is an Associate in the Corporate Team, specialising in our Healthcare, Digital Health & Life Sciences and Technology & Digital Transformation sectors.

Charles advises on venture capital transactions, private equity investments and mergers and acquisitions. He is a member of the firm's technology practice, and the healthcare and life sciences team, advising companies and investors in each sector on their transactions.

Charles is also member of the team of lawyers at Ashfords dealing with enquiries relating to the National Security and Investment Act 2021, and regularly advises on drafting and submitting notifications to the Investment Security Unit.

Outside of Ashfords, Charles is a non-executive director at the Forest of Avon Trust.

Relevant experience

Iksuda Therapeutics: advising a UK oncology research and development business on its $47 million financing round.
eConsult Health: facilitating the acquisition of a UK health tech company, Q Doctor, via a share-for-share exchange.
Advising market leading investors BGF and Parkwalk on a number of co-investments into scaling businesses, including health-tech business Pathfinder Medical as part of an £8 million funding round
National Security and Investment Act 2021: advising various clients on the impact of this legislation on transactions, drafting and submitting notifications to the Investment Security Unit.

Specialisms

Corporate

Technology & Digital Transformation

Healthcare, Digital Health & Life Sciences

Testimonial

Charles Davies, with his prompt responses and continuous support, was always ready to assist us. His proactive approach and attention to detail ensured that no question went unanswered and every issue was addressed promptly and efficiently.

CEO of a scaling Technology business, in relation to a sale of all founder and management shareholdings to an acquirer